These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18364724)

  • 1. Five donors-one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors.
    Schöttker B; Feuchtinger T; Schumm M; Klinker E; Handgretinger R; Einsele H; Stuhler G
    Nat Clin Pract Oncol; 2008 May; 5(5):291-5. PubMed ID: 18364724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recipient-derived cells after cord blood transplantation: dynamics elucidated by multicolor FACS, reflecting graft failure and relapse.
    Watanabe N; Takahashi S; Ishige M; Ishii Y; Ooi J; Tomonari A; Tsukada N; Konuma T; Kato S; Sato A; Tojo A; Nakauchi H
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):693-701. PubMed ID: 18489995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Lee S; Kim YJ; Chung NG; Lim J; Lee DG; Kim HJ; Min CK; Lee JW; Min WS; Kim CC
    Cancer; 2009 Feb; 115(3):561-70. PubMed ID: 19117346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemia.
    Tomonari A; Takahashi S; Shimohakamada Y; Ooi J; Takasugi K; Ohno N; Konuma T; Uchimaru K; Tojo A; Odawara T; Nakamura T; Iwamoto A; Asano S
    Bone Marrow Transplant; 2005 Aug; 36(3):261-2. PubMed ID: 15908966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Limited but potential efficacy by graft-versus-leukemia (GVL) for Pro T-ALL].
    Imataki O; Koike A; Iwabu M; Shintani T; Waki F; Ohue Y; Ohnishi H; Ishida T
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1911-4. PubMed ID: 19011341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
    Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
    Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune reconstitution after cord blood transplants supported by coinfusion of mobilized hematopoietic stem cells from a third party donor.
    Martín-Donaire T; Rico M; Bautista G; Gonzalo-Daganzo R; Regidor C; Ojeda E; Sanjuán I; Forés R; Ruiz E; Krsnik I; Navarro B; Gil S; Magro E; Millán I; Sánchez R; Pérez-Sanz N; Panadero N; García-Marco JA; Cabrera R; Fernández MN
    Bone Marrow Transplant; 2009 Aug; 44(4):213-25. PubMed ID: 19252533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated toxoplasmosis resulting in graft failure in a cord blood stem cell transplant recipient.
    Goebel WS; Conway JH; Faught P; Vakili ST; Haut PR
    Pediatr Blood Cancer; 2007 Feb; 48(2):222-6. PubMed ID: 16333839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation from donors with mosaic Turner syndrome.
    Manola KN; Sambani C; Karakasis D; Baltathakis I; Zoumbos N; Symeonidis A
    Bone Marrow Transplant; 2006 Sep; 38(5):385-6. PubMed ID: 16915227
    [No Abstract]   [Full Text] [Related]  

  • 12. Natural killer/T-cell nasal-type lymphoma: unusual primary spinal tumor.
    Yang C; Ma J; Yang X; Jia L; Liu H; Xiao J
    Spine (Phila Pa 1976); 2008 Nov; 33(24):E929-32. PubMed ID: 19011534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse.
    Pulsipher MA; Bader P; Klingebiel T; Cooper LJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):62-71. PubMed ID: 19147081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rescue by hematopoietic progenitor cells derived from engrafted cord blood unit in a child with brain tumor after transplantation for T-cell acute lymphoblastic leukemia.
    Jaing TH; Tseng CK; Mun-Ching Wong A; Lo WC; Wu CT; Ou LS
    J Pediatr Hematol Oncol; 2012 Oct; 34(7):573-5. PubMed ID: 22430590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-CSF-mobilised granulocyte transfusion to an ALL patient complicated by cytomegalovirus transmission.
    Meyer-Koenig U; Hufert FT; Duffner U; Neumann-Haefelin D; Henschen M
    Bone Marrow Transplant; 2004 Dec; 34(12):1095-6. PubMed ID: 15502855
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cord blood transplantation for acute lymphoblastic leukemia in children: analysis at a single institution].
    Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A; Yoshida M
    Rinsho Ketsueki; 2008 Dec; 49(12):1593-8. PubMed ID: 19110519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM Study Group.
    Bader P; Kreyenberg H; Henze GH; Eckert C; Reising M; Willasch A; Barth A; Borkhardt A; Peters C; Handgretinger R; Sykora KW; Holter W; Kabisch H; Klingebiel T; von Stackelberg A;
    J Clin Oncol; 2009 Jan; 27(3):377-84. PubMed ID: 19064980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploidentical SCT in children: an update and future perspectives.
    Lang P; Handgretinger R
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S54-9. PubMed ID: 18978746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.